Chk2 down-regulation by promoter hypermethylation in human bulk gliomas

Angele, 2003, Altered expression of DNA double-strand break detection and repair proteins in breast carcinomas, Histopathology, 43, 347, 10.1046/j.1365-2559.2003.01713.x Banin, 1998, Enhanced phosphorylation of p53 by ATM in response to DNA damage, Science, 281, 1674, 10.1126/science.281.5383.1674 Bao, 2006, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, 444, 756, 10.1038/nature05236 Bartek, 2003, Chk1 and Chk2 kinases in checkpoint control and cancer, Cancer Cell, 3, 421, 10.1016/S1535-6108(03)00110-7 Bartkova, 2006, Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints, Nature, 444, 633, 10.1038/nature05268 Bondy, 2001, Gamma-radiation sensitivity and risk of glioma, Journal of the National Cancer Institute, 93, 1553, 10.1093/jnci/93.20.1553 Canman, 1998, Activation of the ATM kinase by ionizing radiation and phosphorylation of p53, Science, 281, 1677, 10.1126/science.281.5383.1677 Clarke, 1998, Upregulation of ATM in sclerosing adenosis of the breast, Molecular Pathology, 51, 224, 10.1136/mp.51.4.224 Courey, 1989, Synergistic activation by the glutamine-rich domains of human transcription factor Sp1, Cell, 59, 827, 10.1016/0092-8674(89)90606-5 Dong, 2003, Mutations in CHEK2 associated with prostate cancer risk, The American Journal of Human Genetics, 72, 270, 10.1086/346094 Esteve, 2007, Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells, The Journal of Biological Chemistry, 282, 2615, 10.1074/jbc.M606203200 Grunau, 2001, Bisulfite genomic sequencing: systematic investigation of critical experimental parameters, Nucleic Acids Research, 29, E65, 10.1093/nar/29.13.e65 Hirao, 2000, DNA damage-induced activation of p53 by the checkpoint kinase Chk2, Science, 287, 1824, 10.1126/science.287.5459.1824 Hoeijmakers, 2007, Genome maintenance mechanisms are critical for preventing cancer as well as other aging-associated diseases, Mechanisms of Ageing and Development, 128, 460, 10.1016/j.mad.2007.05.002 Hunter, 1995, When is a lipid kinase not a lipid kinase? When it is a protein kinase, Cell, 83, 1, 10.1016/0092-8674(95)90225-2 Kairouz, 1999, ATM protein synthesis patterns in sporadic breast cancer, Molecular Pathology, 52, 252, 10.1136/mp.52.5.252 Kim, 2009, Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features, Lung Cancer, 65, 247, 10.1016/j.lungcan.2009.03.011 Lania, 1997, Transcriptional regulation by the Sp family proteins, The International Journal of Biochemistry and Cell Biology, 29, 1313, 10.1016/S1357-2725(97)00094-0 Liang, 2009, DNA damage response pathways in tumor suppression and cancer treatment, World Journal of Surgery, 33, 661, 10.1007/s00268-008-9840-1 Lipton, 2003, Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma, Cancer Letters, 200, 149, 10.1016/S0304-3835(03)00391-4 Little, 1998, Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy, International Journal of Cancer, 78, 269, 10.1002/(SICI)1097-0215(19981029)78:3<269::AID-IJC1>3.0.CO;2-T Lu, 2006, Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors, Carcinogenesis, 27, 848, 10.1093/carcin/bgi302 Lukas, 2003, Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage, Nature Cell Biology, 5, 255, 10.1038/ncb945 McKinnon, 2007, DNA strand break repair and human genetic disease, Annual Review of Genomics and Human Genetics, 8, 37, 10.1146/annurev.genom.7.080505.115648 Morgan, 1998, DNA double-strand breaks, chromosomal rearrangements, and genomic instability, Mutation Research, 404, 125, 10.1016/S0027-5107(98)00104-3 Reddy, 2002, Analysis of CHK2 in vulval neoplasia, British Journal of Cancer, 86, 756, 10.1038/sj.bjc.6600131 Rich, 2007, Cancer stem cells in radiation resistance, Cancer Research, 67, 8980, 10.1158/0008-5472.CAN-07-0895 Sanai, 2005, New stem cells and the origin of gliomas, New England Journal of Medecine, 353, 811, 10.1056/NEJMra043666 Sancar, 2004, Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints, Annual Review of Biochemistry, 73, 39, 10.1146/annurev.biochem.73.011303.073723 Schwartzbaum, 2006, Epidemiology and molecular pathology of glioma, Nature Clinical Practice Neurology, 2, 494, 10.1038/ncpneuro0289 Takai, 2002, Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription, The EMBO Journal, 21, 5195, 10.1093/emboj/cdf506 Tibbetts, 1999, A role for ATR in the DNA damage-induced phosphorylation of p53, Genes and Development, 13, 152, 10.1101/gad.13.2.152 Tort, 2002, CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas, Blood, 100, 4602, 10.1182/blood-2002-04-1078 Walker, 2009, Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity, Oncogene, 28, 2314, 10.1038/onc.2009.102 Wang, 2009, REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy, Neuro-Oncology, 11, 790, 10.1215/15228517-2009-015 Williams, 2006, Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers, Clinical Cancer Research, 12, 6967, 10.1158/1078-0432.CCR-06-1770 Xiao, 2003, Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents, Journal of Biological Chemistry, 278, 21767, 10.1074/jbc.M300229200 Zhang, 2004, CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer, Molecular Cancer, 3, 14, 10.1186/1476-4598-3-14 Zhao, 2001, ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1, Molecular Cell Biology, 21, 4129, 10.1128/MCB.21.13.4129-4139.2001